DUBLIN, Apr. 24, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Genome Editing/Genome Engineering Market by Technology, Applications, and End User - Global Forecast to 2021" report to their offering.
The genome editing market is projected to reach USD 5.54 Billion by 2021 from USD 2.84 Billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021).
Owing to factors such as high prevalence rate of infectious diseases and cancer among patients, technological advancements, rising government funding and growth in the number of genomics projects, increasing demand for synthetic genes, growing awareness about genomics, and increasing new product launches by industry players are expected to drive the market in the coming years. Rise in the production of genetically modified crops is also expected to increase the demand for genome editing.
The global genome editing market is segmented on the basis of technology, application end user. By technology, the market is categorized into RISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, and Jump-In). The CRISPR segment is projected to command the largest share of the global market. This segment is also expected to grow at the highest growth rate in the forecast period. The large market share and high growth rate of CRISPR technology segment can be attributed to the ease of use associated with the technology and reduction in off-target effect of CRISPR.
By application, the global genome editing market is categorized into cell line engineering, plant genetic engineering, animal genetic engineering, and other applications (diagnostics and therapeutics). The cell line engineering segment is projected to have the highest growth rate in 2016-2021. This segment account for the largest share of the global market in 2016. Factors such as such as growing industry focus on stem cell research and increasing global awareness about stem cell therapies through various organizations and increasing funding from governments and private organizations are driving the growth of the cell line engineering applications segment.
- Genscript USA Inc.
- Horizon Discovery Group PLC
- Integrated DNA Technologies, Inc.
- Lonza Group Ltd.
- Merck KGaA
- New England Biolabs, Inc.
- Origene Technologies, Inc.
- Sangamo Biosciences, Inc.
- Thermo Fisher Scientific, Inc.
- Transposagen Biopharmaceuticals, Inc.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Genome Editing/Engineering Market, By Technology
7 Global Genome Editing/Genome Engineering Market, By Application
8 Global Genome Editing/Engineering Market, By End User
9 Genome Editing/Genome Engineering Market, By Region
10 Competitive Landscape
11 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/slp397/genome
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/genome-editing-market-to-reach-usd-554-billion-by-2021-driven-by-an-increasing-demand-for-synthetic-genes--rising-government-funding---research-and-markets-300443612.html
SOURCE Research and Markets